We take great pride in everything that we do, control over products and supply allows us to ensure our customers receive the best quality service. Contact us via the form below or on the following email [email protected] to register your enquiry with us.
Foresta is building a plant in Bay of Plenty, New Zealand where we will manufacture pine chemicals and pine wood pellets; completely transforming the energy industry by providing a clean energy source. This will be a direct coal replacement, we welcome your enquiry to partner with us as a wood pellet customer or forestry provider.
Foresta is rethinking industry processes. From transforming harvesting and replanting methods to ensure long-term sustainability, to the eco-friendly manufacturing processes, ensuring only natural chemicals are used resulting in no toxic residues. Our goal is to provide clean and safe products that positively impact daily life. By collaborating with local farmers, Iwi, and governments, we’re committed to enhancing forest health and driving meaningful change.
Foresta has taken a best supplier, best practice approach to designing and planning its operations. Ensuring that the most energy efficient and lowest environmentally impacting processes are used in its operations, whilst achieving the highest quality products supported by the best suppliers in our industry.
We developed our own patented extraction process for the renewable natural chemicals that uses the natural oils of the pine tree as the extractive, eliminating nearly 25% of extra processing and petrochemicals.
Our process increases the potential income from the pine wood, ensuring a truly sustainable future for pine, at the same time we enable real decarbonisation of our nation.
The company Essential Queensland Pty Ltd was formed in 2017, we had a pilot plant in Childers Queensland, Australia where we produced turpentine and rosin. In December 2020 we completed a backdoor listing on Leaf Resources Ltd, we continued to operate in Childers however once recognising the great potential in forestry supply in New Zealand, we made the decision to move our operations to NZ. We then acquired a large scale commercial plant that will be erected in Rotorua, New Zealand under the name of Foresta (NZ) Limited.
Mr Henry Cheng is a senior management and board executive with over 35 years of extensive experience in international business, resources, insurance, investment, finance and banking.
Henry has developed strong global networks, having travelled extensively and worked in many countries. He has forged well established and influential relationships at senior executive and board level with publicly-listed and private companies as well as leading financial institutions and government entities across Asia, USA, Europe and UK.
Henry is a Graduate of the National Taiwan University and holds a Bachelor of Business and Master of Business (International Finance). Henry currently serves as Executive Chairman of Formosa Group Australia, Executive Chairman of Formosa Resources and Executive Chairman of Arizona Global Transaction Management Services. He was previously the Managing Director of Manulife Insurance and General Manager of Halifax as well as a Director of the Australian Patients Association (APA).
Dr Maurice Fabiani is a senior management and board executive with over 30 years’ experience in international business as well as the biomedical field and related health areas. He has an extensive professional background, having held senior roles in business, academia, biomedical/biotechnology industry and the not-for-profit sector.
Dr Fabiani is a Graduate of the University of Melbourne and holds a PhD (Medicine/Pharmacology) as well as MBA (Finance and Strategy) from the Melbourne Business School. He is also a Graduate of the Australian Institute of Company Directors.
Dr Fabiani is currently the Chief Executive Officer of Formosa Group Australia. He was previously a Senior Research Fellow in the Department of Medicine, University of Melbourne, and head of an internationally recognised medical research group. He is also a published author of many international peer-reviewed scientific and medical research publications. Dr Fabiani has served as CEO and Managing Director of biotechnology companies as well as a Founding Director and Chairman of the Australian Patients Association (APA).
Russell Allen is a highly successful businessman, entrepreneur and investor. Mr Allen has over 40 years’
experience across several industries including international business, global trading, transport and logistics,
construction, retail, hospitality, property development and investment. He has built, owned and operated several
successful businesses over his career. He was previously Managing Director of Alenco Pty Ltd and Noirot Pty Ltd.
Mr Allen is currently Managing Director of Formosa Group Australia Pty Ltd. Mr Allen has a wealth of business
experience, expertise and acumen, and represents a valuable addition to the Board.
Grant is a co-founder, having been involved in EQ since its incorporation in 2017, providing guidance on intellectual property development and the management and company growth.